A detailed history of Byrne Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Byrne Asset Management LLC holds 32,665 shares of PFE stock, worth $873,462. This represents 0.78% of its overall portfolio holdings.

Number of Shares
32,665
Previous 34,145 4.33%
Holding current value
$873,462
Previous $947,000 3.59%
% of portfolio
0.78%
Previous 0.79%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $37,384 - $43,808
-1,480 Reduced 4.33%
32,665 $913,000
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $27,521 - $31,602
-1,063 Reduced 3.02%
34,145 $947,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $109,876 - $142,717
-4,205 Reduced 10.67%
35,208 $1.01 Million
Q3 2023

Oct 31, 2023

SELL
$32.09 - $37.51 $44,605 - $52,138
-1,390 Reduced 3.41%
39,413 $1.31 Million
Q2 2023

Jul 21, 2023

BUY
$36.12 - $41.79 $27,089 - $31,342
750 Added 1.87%
40,803 $1.5 Million
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $25,012 - $32,562
-635 Reduced 1.56%
40,053 $1.63 Million
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $64,086 - $83,657
-1,535 Reduced 3.64%
40,688 $2.09 Million
Q3 2022

Oct 19, 2022

BUY
$43.76 - $53.42 $7,439 - $9,081
170 Added 0.4%
42,223 $1.85 Million
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $6,979 - $8,275
-150 Reduced 0.36%
42,053 $2.21 Million
Q1 2022

Apr 05, 2022

BUY
$45.75 - $56.69 $76,631 - $94,955
1,675 Added 4.13%
42,203 $2.19 Million
Q4 2021

Feb 22, 2022

BUY
$41.32 - $61.25 $1.67 Million - $2.48 Million
40,528 New
40,528 $2.39 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Byrne Asset Management LLC Portfolio

Follow Byrne Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.